Meta menu:

From here, you can access the Emergencies page, Contact Us page, Accessibility Settings, Language Selection, and Search page.

Open Menu
Research in the laboratory

Clinical Trials | Clinical Research

The Charité Institute of Allergology is constantly carrying out numerous clinical trials. We have summarised the most important information for you below.

You are here:

Clinical trials are scientific investigations carried out using precisely defined and strictly controlled conditions. They are used for the development and testing of new therapeutic methods or medications. The most common form of clinical trial, the clinical testing of new drugs, is testing carried out on humans with the objective of researching or proving the clinical or pharmacological efficacy of medicinal products, as well as identifying possible side effects. There are also clinical trials to determine the effectiveness and/or reliability of medical devices.

For almost 20 years, our study center has offered participation in clinical trials for all indications seen at our clinic. During this time, the quality of life of many outpatients with allergological or allergy-like diseases has fundamentally improved. Our first self-initiated trial of the interaction between antihistamines and itching-induced stress in patients with chronic urticaria was carried out in 2004. The following year, we carried out a pharmacological trial on people suffering from hereditary angioedema (HAE). The impact of these trials continues to be felt as the active ingredients studied at the time (ebastine for urticaria and icatibant for HAE) are now both part of the standard care for each respective condition. Since this time, our study center has become a contact point for many patients and has evolved into a nationally and internationally renowned reference center for allergological diseases. Our team, comprised of study assistants, study coordinators, clinical investigators, a team of those completing a year of voluntary social service, and student assistants, provides care to patients in phase I to IV studies in various allergy-related indications.

Our aim is to develop and improve new therapeutic approaches in all our areas of research for our patients. To achieve this, we carry out research at the highest levels and make every effort to achieve a symptom-free future for our patients. Participating in a clinical trial allows you to play an active role in developing new treatment options and improving therapeutic care in this field. We are happy to provide you with more information about ways to participate and we would be delighted if we can inspire you to take part in one of our trials.


House 1 marked on the site plan of Campus Benjamin Franklin
House 1 marked on the site plan of Campus Benjamin Franklin

IFA Study Center
Campus Benjamin Franklin
Hindenburgdamm 30 | House 1
12203 Berlin

Phone: currently not available


Prof. Dr. med. Markus Magerl

Head of Clinical Trials, MD

Portrait of Prof. Dr. Markus Magerl
Loredana Perretta

Assistant to Prof. Dr. Markus Magerl & PD Dr. Frank Siebenhaar

Portrait of Loredana Perretta
Janine Ruhe

Trial Site Lead

Pia Dietrich

Trial Site Lead